Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

235 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Modeling Alzheimer's disease with iPSCs reveals stress phenotypes associated with intracellular Aβ and differential drug responsiveness.
Kondo T, Asai M, Tsukita K, Kutoku Y, Ohsawa Y, Sunada Y, Imamura K, Egawa N, Yahata N, Okita K, Takahashi K, Asaka I, Aoi T, Watanabe A, Watanabe K, Kadoya C, Nakano R, Watanabe D, Maruyama K, Hori O, Hibino S, Choshi T, Nakahata T, Hioki H, Kaneko T, Naitoh M, Yoshikawa K, Yamawaki S, Suzuki S, Hata R, Ueno S, Seki T, Kobayashi K, Toda T, Murakami K, Irie K, Klein WL, Mori H, Asada T, Takahashi R, Iwata N, Yamanaka S, Inoue H. Kondo T, et al. Among authors: sunada y. Cell Stem Cell. 2013 Apr 4;12(4):487-96. doi: 10.1016/j.stem.2013.01.009. Epub 2013 Feb 21. Cell Stem Cell. 2013. PMID: 23434393 Free article.
Calcium dysregulation contributes to neurodegeneration in FTLD patient iPSC-derived neurons.
Imamura K, Sahara N, Kanaan NM, Tsukita K, Kondo T, Kutoku Y, Ohsawa Y, Sunada Y, Kawakami K, Hotta A, Yawata S, Watanabe D, Hasegawa M, Trojanowski JQ, Lee VM, Suhara T, Higuchi M, Inoue H. Imamura K, et al. Among authors: sunada y. Sci Rep. 2016 Oct 10;6:34904. doi: 10.1038/srep34904. Sci Rep. 2016. PMID: 27721502 Free PMC article.
Repurposing bromocriptine for Aβ metabolism in Alzheimer's disease (REBRAnD) study: randomised placebo-controlled double-blind comparative trial and open-label extension trial to investigate the safety and efficacy of bromocriptine in Alzheimer's disease with presenilin 1 (PSEN1) mutations.
Kondo T, Banno H, Okunomiya T, Amino Y, Endo K, Nakakura A, Uozumi R, Kinoshita A, Tada H, Morita S, Ishikawa H, Shindo A, Yasuda K, Taruno Y, Maki T, Suehiro T, Mori K, Ikeda M, Fujita K, Izumi Y, Kanemaru K, Ishii K, Shigenobu K, Kutoku Y, Sunada Y, Kawakatsu S, Shiota S, Watanabe T, Uchikawa O, Takahashi R, Tomimoto H, Inoue H. Kondo T, et al. Among authors: sunada y. BMJ Open. 2021 Jun 30;11(6):e051343. doi: 10.1136/bmjopen-2021-051343. BMJ Open. 2021. PMID: 34193504 Free PMC article. Clinical Trial.
Mild phenotype of Charcot-Marie-Tooth disease type 4B1.
Murakami T, Kutoku Y, Nishimura H, Hayashi M, Abe A, Hayasaka K, Sunada Y. Murakami T, et al. Among authors: sunada y. J Neurol Sci. 2013 Nov 15;334(1-2):176-9. doi: 10.1016/j.jns.2013.08.001. Epub 2013 Aug 9. J Neurol Sci. 2013. PMID: 23962696
Follistatin-derived peptide expression in muscle decreases adipose tissue mass and prevents hepatic steatosis.
Nakatani M, Kokubo M, Ohsawa Y, Sunada Y, Tsuchida K. Nakatani M, et al. Among authors: sunada y. Am J Physiol Endocrinol Metab. 2011 Mar;300(3):E543-53. doi: 10.1152/ajpendo.00430.2010. Epub 2011 Jan 4. Am J Physiol Endocrinol Metab. 2011. PMID: 21205933 Free article.
We previously reported the development and characterization of several follistatin-derived peptides, including FS I-I (Nakatani M, Takehara Y, Sugino H, Matsumoto M, Hashimoto O, Hasegawa Y, Murakami T, Uezumi A, Takeda S, Noji S, Sunada Y, Tsuchida K. …
We previously reported the development and characterization of several follistatin-derived peptides, including FS I-I (Nakatani M, Takehara …
235 results